- Home
- XOMAP vs APCX Comparison
XOMAP vs APCX Comparison
Compare XOMAP & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMAP
- APCX
- Stock Information
- Founded
- XOMAP N/A
- APCX 2006
- Country
- XOMAP United States
- APCX United States
- Employees
- XOMAP 13
- APCX N/A
- Industry
- XOMAP Biotechnology: Pharmaceutical Preparations
- APCX Finance: Consumer Services
- Sector
- XOMAP Health Care
- APCX Finance
- Exchange
- XOMAP Nasdaq
- APCX Nasdaq
- Market Cap
- XOMAP N/A
- APCX N/A
- IPO Year
- XOMAP N/A
- APCX N/A
- Fundamental
- Price
- XOMAP $26.08
- APCX $0.47
- Analyst Decision
- XOMAP
- APCX
- Analyst Count
- XOMAP 0
- APCX 0
- Target Price
- XOMAP N/A
- APCX N/A
- AVG Volume (30 Days)
- XOMAP N/A
- APCX 127.8K
- Earning Date
- XOMAP N/A
- APCX 11-14-2024
- Dividend Yield
- XOMAP N/A
- APCX N/A
- EPS Growth
- XOMAP N/A
- APCX N/A
- EPS
- XOMAP N/A
- APCX N/A
- Revenue
- XOMAP N/A
- APCX $365,000.00
- Revenue This Year
- XOMAP N/A
- APCX $1,315.48
- Revenue Next Year
- XOMAP N/A
- APCX N/A
- P/E Ratio
- XOMAP N/A
- APCX N/A
- Revenue Growth
- XOMAP N/A
- APCX N/A
- 52 Week Low
- XOMAP N/A
- APCX $0.44
- 52 Week High
- XOMAP N/A
- APCX $2.30
- Technical
- Relative Strength Index (RSI)
- XOMAP 52.06
- APCX 27.08
- Support Level
- XOMAP $25.72
- APCX $0.45
- Resistance Level
- XOMAP $26.00
- APCX $0.73
- Average True Range (ATR)
- XOMAP 0.18
- APCX 0.08
- MACD
- XOMAP -0.03
- APCX -0.02
- Stochastic Oscillator
- XOMAP 49.64
- APCX 5.84
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.